Osteoporosis in a murine model of postmenopausal lupus.


Journal

Lupus
ISSN: 1477-0962
Titre abrégé: Lupus
Pays: England
ID NLM: 9204265

Informations de publication

Date de publication:
Jan 2020
Historique:
pubmed: 12 12 2019
medline: 2 6 2020
entrez: 12 12 2019
Statut: ppublish

Résumé

Postmenopausal women with systemic lupus erythematosus have an increased risk of osteoporosis and associated fractures. Their increased osteoporosis risk is probably caused by a high level of inflammation, use of glucocorticoids, impaired kidney function, and early menopause as these are known risk factors for osteoporosis. Due to these risk factors and the lack of safe and effective treatments, new therapies for the treatment of osteoporosis in this group of patients are needed. Ovariectomized MRL/ Skeletal parameters were measured in MRL/ Total bone mineral density was reduced in MRL/ Ovariectomized MRL/

Sections du résumé

BACKGROUND/OBJECTIVE OBJECTIVE
Postmenopausal women with systemic lupus erythematosus have an increased risk of osteoporosis and associated fractures. Their increased osteoporosis risk is probably caused by a high level of inflammation, use of glucocorticoids, impaired kidney function, and early menopause as these are known risk factors for osteoporosis. Due to these risk factors and the lack of safe and effective treatments, new therapies for the treatment of osteoporosis in this group of patients are needed. Ovariectomized MRL/
METHODS METHODS
Skeletal parameters were measured in MRL/
RESULTS RESULTS
Total bone mineral density was reduced in MRL/
CONCLUSION CONCLUSIONS
Ovariectomized MRL/

Identifiants

pubmed: 31825765
doi: 10.1177/0961203319893759
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

58-66

Auteurs

J Nordqvist (J)

Department of Rheumatology and Inflammation Research, Centre for Bone and Arthritis Research, University of Gothenburg, Sweden.

M K Lagerquist (MK)

Department of Internal Medicine and Clinical Nutrition, Centre for Bone and Arthritis Research, University of Gothenburg, Sweden.

L Grahnemo (L)

Department of Internal Medicine and Clinical Nutrition, Centre for Bone and Arthritis Research, University of Gothenburg, Sweden.

A Koskela (A)

Department of Anatomy and Cell Biology, University of Oulu, Finland.

U Islander (U)

Department of Internal Medicine and Clinical Nutrition, Centre for Bone and Arthritis Research, University of Gothenburg, Sweden.

H Carlsten (H)

Department of Rheumatology and Inflammation Research, Centre for Bone and Arthritis Research, University of Gothenburg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH